1. Introduction {#sec1}
===============

Both diabetes and ankle fractures are increasing in incidence worldwide. In 2003, it was estimated that 194 million people in the world have been diagnosed with diabetes and this is predicted to exponentially increase to over 333 million by 2025 \[[@B1]\]. Ankle fractures are amongst the most common injuries encountered by orthopaedic surgeons, with its incidence on the rise in parallel with general life expectancy \[[@B2], [@B3]\]. Extrapolated from this data, the incidence of diabetic ankle fractures will inevitably increase. There is, however, a lack in a standardized diagnostic and treatment guidelines for diabetic ankle fractures. Additionally and not uncommonly, diabetic ankle fractures have been misdiagnosed resulting in delayed management. For these reasons, we propose a diagnostic and management algorithm that incorporates a quantitative scoring system in hope to achieve a practical approach to this complex and challenging problem.

2. Materials and Methods {#sec2}
========================

Publications were identified by conducting a comprehensive keyword search of Medline, EMBASE, and CINAHL databases between the months of September 2010 to March 2011 by the primary author (Joshua Yee). Search terms included "diabetes," "ankle," and "fracture." Available abstracts of all articles (i.e., no date restriction to search results) published in the English language in the above databases searched within the above timeframe where included for initial review to determine suitability. Inclusion criteria for full-text review were that articles must be relevant to diabetic ankle fracture diagnosis and management. Manual search of the all the references in the full-text publications was also completed to further identify additional publications for potential inclusion. All included full-text publications for review were further defined as either a notable or supportive. A publication was defined to be notable if the study design (i.e., cohort, retrospective, case control, and case series) and level of prognostic strength (i.e., level IV or higher) were met. Notable publications were subjected to further critical analysis. Exclusion criteria were the following: publications not published in English; all conferences, lectures, review articles, and publications that were neither published nor published in the above databases. Duplicate results that occurred in different databases were truncated to a single result.

3. Results {#sec3}
==========

A total of 352 abstracts were initially screened. From these abstracts, 59 articles met our inclusion criteria for further full text review. 293 articles were excluded. Nine additional articles were found after reviewing all the full-text references ([Figure 1](#fig1){ref-type="fig"}). Nineteen notable papers were identified for further critical analysis (Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}). From these results, we propose the Adelaide Fracture in the Diabetic Ankle (AFDA) algorithm and score (Figures [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}, [Table 3](#tab3){ref-type="table"}).

4. Discussion {#sec4}
=============

The AFDA algorithm consists of two parts: a diagnostic and management part (Figures [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}), having its own respective goals. The diagnostic part is targeted for primary care physicians and nurse practitioners with a goal to accurately and timely provide a diagnosis to any presentation of ankle redness, swelling, and/or pain; and if such a presentation is encountered, the algorithm progresses to assess or screen for the presence and risks for diabetes.

Risk factors for diabetes include previous history of impaired glucose intolerance; high-risk ethnic groups (i.e., Asian, African, and Hispanic); positive family history or gestational diabetes; age greater than or equal to 45 with either a body mass index (BMI) greater or equal to 25 or presence of hypertension; and established cardiovascular risk factors or disease. If risk factors are present, screening for diabetes is suggested using either HBA1c (greater or equal to 6.5%), two-hour plasma glucose (greater or equal to 11.1 mmol/L) during an oral glucose tolerance test, or fasting blood glucose (greater or equal to 7.0 mmol/L) \[[@B4]\].

If the presence of diabetes has been excluded, other causes of ankle redness, swelling, and/or pain should be considered, which can include: gout, infection, septic arthritis, deep vein thrombosis (DVT), and haemarthrosis \[[@B5], [@B6]\]. Furthermore, if there is an absence of systemic signs of infection (i.e., fever, elevated white cell count, or CRP), then infection is unlikely \[[@B6]\].

Since the introduction of the Ottawa ankle rules \[[@B7]\], there has been a significant increase in cost efficiency to plain radiograph usage in assessing acute ankle injuries. However, there has been question of whether the Ottawa ankle rules apply in diabetics \[[@B8], [@B9]\]. If there is a history of diabetes or newly diagnosed diabetes, we suggest that plain radiographs can be acquired independent of the Ottawa ankle rules. This should be interpreted for presence of a fracture, dislocation, and/or Charcot\'s arthropathy. Because of the possibility of an insensate lower limb, the patient\'s history may be difficult to elicit which has occurred first: the fracture or acute Charcot\'s. However, if any of these are present, the AFDA management algorithm and score can be applied.

The AFDA management algorithm and score will assist the treating specialist in the optimal decision making for managing diabetic ankle fractures. If a fracture requires fixation, the AFDA score ([Table 3](#tab3){ref-type="table"}) can be considered to differentiate between managing it as a primary ORIF or primary rigid fixation/arthrodesis. Ganesh et al. \[[@B3]\] have, in an analysis of a nationwide inpatient database, concluded that there are significant increases in in-hospital length of stay and costs for diabetics with ankle fractures compared with nondiabetics. Having a decision from the outset can potentially decrease these factors and, furthermore, allow the patient to return to their usual activities earlier and save them from unnecessary revision surgery. Rigid fixation/arthrodesis is reserved for patients who are at high risk of amputation or failure if primary ORIF is used. Comparing techniques of rigid fixation/arthrodesis is beyond the scope of this discussion, but options include retrograde intramedullary nailing \[[@B10], [@B11]\], posterior blade plate \[[@B12]\], external ring fixators \[[@B13]\], and cross-screw techniques \[[@B14]\].

If Charcot\'s arthropathy is present in conjunction with the diabetic ankle fracture, Eichenholtz\'s \[[@B15]\] staging should also be considered. As Eichenholtz stage I has traditionally been considered to be the acute fragmentation stage, the current literature recommends that this stage can be managed nonoperatively in the interim, with nonweight bearing and serial total contact casting. Additionally, frequent followup and further patient optimization through multidisciplinary review and management can be considered. Endocrine input for consideration of intravenous bisphosphonate therapy (i.e., Pamindronate) has been shown to inhibit the increased osteoclastic activity that weakens bones during this acute stage \[[@B16], [@B17]\]. Optimization of diabetic control, nutrition, and vascular status whilst this stage progresses will likely achieve a better outcome. Once Eichenholtz\'s staging progresses outside of stage I, progression for fixation consideration is suggested. Postoperatively and independent from the surgical fixation technique, the literature suggests that all patients undergo prolonged nonweightbearing for 12 weeks, protected or partial weight bearing for another 8 to 12 weeks, with frequent outpatient followup with plain radiographs initially fortnightly for the first six weeks, then monthly thereafter \[[@B18]\].

The AFDA scoring system ([Table 3](#tab3){ref-type="table"}) is based on assessable patient factors. Two points have been allocated to factors more readily seen in the notable publications to suggest either poor outcomes of standard internal fixation or better outcomes with rigid fixation/arthrodesis. A Semmes Weinstein monofilament 10 g/5.07 at the plantar aspect of either the great toe, first, third, or fifth metatarsal head can be used to assess presence of neuropathy \[[@B18]\]. Presence of vasculopathy can be defined as peripheral oxygen saturations consistently less than 95% or an ABI of less than 0.65 \[[@B19]\]. Obesity can be defined as a BMI of greater than 30. Smoking has not been included as a factor because it increases general surgical risk, independent of fixation technique.

With the use of AFDA algorithm, it can hopefully provide a standardized approach and guide to management for diabetic ankle fractures. The scoring system, in particular, can assist in objectively quantifying risk for both the patient and affected ankle joint so as to allow the treating specialist to have confidence in achieving the best possible outcome. As the score increases, the risks of failure in standard fixation methods increase and consideration of more robust and rigid fixation techniques or fusion should be incorporated. From our review of the literature, we suggest that if the patient scores five or more, rigid fixation/arthrodesis should be considered from the outset. If rigid fixation/arthrodesis fails, despite adequate measures in hope for an optimal outcome, amputation can be considered.

The current evidence of which AFDA is derived from is based primarily on heterogeneous study designs and our center\'s experience. As such, it will require further validation reviews or trials, incorporating followup and functional outcome scores. Once validated, AFDA can be used as a protocol and research tool for the diagnosis and management of diabetic ankle fractures.
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###### 

Notable publications in detail.

  Study type                      Total number of studies   Publication details
  ------------------------------- ------------------------- --------------------------------
  Review articles                 3                         Wukich and Kline \[[@B2]\]
  Prisk and Wukich \[[@B18]\]                               
  Myerson and Edwards \[[@B6]\]                             
                                                            
  Cohort study                    1                         Guo et al. \[[@B20]\]
                                                            
  Retrospective study             2                         SooHoo et al. \[[@B21]\]
  Ganesh et al. \[[@B3]\]                                   
                                                            
  Case control study              6                         McCormack and Leith \[[@B22]\]
  Jones et al. \[[@B23]\]                                   
  Flynn et al. \[[@B24]\]                                   
  Blotter et al. \[[@B25]\]                                 
  Kristiansen \[[@B26]\]                                    
  Bibbo et al. \[[@B27]\]                                   
                                                            
  Case series                     7                         Costigan et al. \[[@B28]\]
  Ayoub \[[@B14]\]                                          
  Holmes and Hill \[[@B29]\]                                
  Kline et al. \[[@B30]\]                                   
  White et al. \[[@B31]\]                                   
  Schon et al. \[[@B32]\]                                   
  Low and Tan \[[@B33]\]                                    

###### 

Critical analysis of the notable publications.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study type                    Authors, year, and location origin   Prognostic\                                                                                                                                               Patient details                                                                                                                                                                  Relevant findings
                                                                     evidence strength                                                                                                                                                                                                                                                                                                                          
  ----------------------------- ------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------
  Cohort study                  Guo et al. \[[@B20]\]\               Level II                                                                                                                                                  \(i\) Retrospectively selected 72 patients (36 preoperatively neglected diabetes, 36 nondiabetic controls) with closed ankle fractures between 01/03 and 09/07 \                 \(i\) Increased incidence of infection, nonunion, and Charcot\'s arthropathy \
                                China, 2009                                                                                                                                                                                    (ii) Recall of patients for prospective review over 12 months \                                                                                                                  (ii) No significant difference in AOFAS and Bray\'s ankle score between two groups
                                                                                                                                                                                                                               (iii) Managed either nonoperatively and operatively \                                                                                                                            
                                                                                                                                                                                                                               (iv) Mean age 54.4                                                                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                                                                

  Retrospective study           SooHoo et al. \[[@B21]\]\            Level II                                                                                                                                                  57,183 operatively managed ankle fractures (1,219 were complicated diabetic ankle fractures)                                                                                     Significant increase in complication rates (wound infection, revision operation, and BKA) in complicated diabetic group
                                USA, 2009                                                                                                                                                                                                                                                                                                                                                                       

  Ganesh et al. \[[@B3]\]\      Level II                             160,598 nationwide ankle fractures (9174 diabetic ankle fractures) between 1988 and 2000                                                                  Diabetics had significant increase in in-hospital mortality, complications, length of stay, and cost                                                                             
  USA, 2005                                                                                                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                

  Case control                  McCormack and Leith \[[@B22]\]\      Level III                                                                                                                                                 \(i\) 52 patients (26 diabetic, 26 control) with closed ankle fractures between 04/90 and 01/99 \                                                                                Significant increase in complications in both nonoperative and operative fixation in diabetics
                                Canada, 1998                                                                                                                                                                                   (ii) Mean age 61 (43--78)                                                                                                                                                        

  Jones et al. \[[@B23]\]\      Level III                            \(i\) 84 patients (42 diabetic, 42 control)  \                                                                                                            Significant increase in long-term bracing in diabetics (mean age 53.6, insulin dependant, mean duration of DM 20.3 years, and history of Charcot\'s)                             
  USA, 2005                                                          (ii) Mean age 57.1                                                                                                                                                                                                                                                                                                                         

  Flynn et al. \[[@B24]\]\      Level III                            \(i\) 98 patients with closed ankle fractures (25 diabetic, 73 nondiabetic) between 01/88 and 31/97 \                                                     Significant increase in postoperative infection in diabetic group (up to five times), especially with factors: nonoperative management, poor glycaemic control, and neuropathy   
  Puerto Rico, 2000                                                  (ii) Mean age 44 (nondiabetic) and 60 (diabetic)                                                                                                                                                                                                                                                                                           

  Blotter et al. \[[@B25]\]\    Level III                            \(i\) 67 surgically treated ankle fractures in patients (21 diabetic, 46 nondiabetic/control) between 03/85 and 10/96 \                                   \(i\) Significant increase in postoperative complication in diabetic group (43% versus 15%), particularly in the insulin dependent \                                             
  USA, 1999                                                          (ii) 4/21 Webber C, 17/21 Webber B \                                                                                                                      (ii) 2 cases of postoperative Charcot\'s arthropathy in diabetic population \                                                                                                    
                                                                     (iii) Mean age 55 (diabetic group) and 53 (nondiabetic/control group)                                                                                     (iii) No diabetic subgroup analysis                                                                                                                                              

  Kristiansen \[[@B26]\]\       Level III                            30 patients (10 diabetic, 20 nondiabetic/control)                                                                                                         Significantly increase in wound infection (60% versus 10%) and hospitalization in diabetics (17 versus 9 days)                                                                   
  Denmark, 1983                                                                                                                                                                                                                                                                                                                                                                                                 

                                Bibbo et al. \[[@B27]\]\             Level III                                                                                                                                                 \(i\) 59 patients with isolated ankle fractures (13 diabetic, 46 nondiabetic/control)  \                                                                                         \(i\) Increased complication rate in diabetics compared to nondiabetics (46% versus 17%) \
                                USA, 2001                                                                                                                                                                                      (ii) Mean age 55.1 (diabetic), 40.2 (nondiabetic/control)  \                                                                                                                     (ii) None required amputation/arthrodesis \
                                                                                                                                                                                                                               (iii) Mean followup 46 months (diabetic) and 32 months (nondiabetic/control)                                                                                                     (iii) No information on presence of diabetic complications

                                                                                                                                                                                                                                                                                                                                                                                                                

  Case series                   Costigan et al. \[[@B28]\]\          Level IV                                                                                                                                                  \(i\) 84 diabetic patients with previous ORIF of an ankle fracture over an 8-year period \                                                                                       Significant increase in complications in diabetics with peripheral neuropathy and peripheral vascular disease
                                USA, 2007                                                                                                                                                                                      (ii) Mean age 49.5 \                                                                                                                                                             
                                                                                                                                                                                                                               (iii) Average followup 4.1 years                                                                                                                                                 

  Ayoub \[[@B14]\]\             Level IV                             \(i\) 17 patients with Charcot arthropathy undergoing tibiotalar arthrodesis \                                                                            Fusion rates were higher in patients with O~2~ saturations \> 95%, decreased BMI, absence of peripheral neuropathy                                                               
  Egypt, 2008                                                        (ii) Mean age 61.6 (57--69)  \                                                                                                                                                                                                                                                                                                             
                                                                     (iii) Mean followup 26 months                                                                                                                                                                                                                                                                                                              

  Holmes and Hill \[[@B29]\]\   Level IV                             \(i\) Assesses relationship of early diagnosis and treatment in 18 patients with diabetic ankle or foot fracture/dislocations between 05/85 and 05/90 \   11/20 had a delay in diagnosis with average time of 1 month between onset of symptoms and diagnosis                                                                              
  USA, 1994                                                          (ii) Mean age 55 \                                                                                                                                                                                                                                                                                                                         
                                                                     (iii) Mean followup 27 months                                                                                                                                                                                                                                                                                                              

  Kline et al. \[[@B30]\]\      Level IV                             \(i\) 83 tibial pilon fractures (14 diabetic, 68 nondiabetic) between 01/2005 and 06/2007 \                                                               Significant increase in postoperative complications including infection (71% versus 19%) and nonunion/delayed union (43% versus 16%)                                             
  USA, 2009                                                          (ii) Mean age 47.3 \                                                                                                                                                                                                                                                                                                                       
                                                                     (iii) Length of followup 14.5 months (diabetic) and 12.3 months (nondiabetic)                                                                                                                                                                                                                                                              

  White et al. \[[@B31]\]\      Level IV                             \(i\) 14 open ankle fractures in 13 patients with diabetes between 01/01/1981 and 31/12/2000 \                                                            9/14 developed wound complications, 6/14 had below knee amputations (4 of these were at least Gustilo Class III open fractures), and 3/14 healed                                 
  USA, 2003                                                          (ii) Mean age 54 (29--80)  \                                                                                                                                                                                                                                                                                                               
                                                                     (iii) Mean followup 19 months \                                                                                                                                                                                                                                                                                                            
                                                                     (iv) 9/13 patients were insulin dependent                                                                                                                                                                                                                                                                                                  

  Schon et al. \[[@B32]\]\      Level IV                             28 diabetic neuropathic ankle fractures (15 undisplaced, 13 displaced)                                                                                    \(i\) Undisplaced ankle fractures are amenable to nonoperative management without significant complications \                                                                    
  USA, 1998                                                                                                                                                                                                                    (ii) Of the 13 displaced ankle fractures, high risk of malunion/nonunion if standard ORIF is used                                                                                

  Low and Tan \[[@B33]\]\       Level IV                             \(i\) 93 surgically treated ankle fractures (83 nondiabetic, 10 diabetic) between 01/1992 and 06/1993 \                                                   \(i\) 5 reported cases of infection (all diabetics)  \                                                                                                                           
  Singapore, 1995                                                    (ii) Mean age 67.5 \                                                                                                                                      (ii) 2/5 requiring below knee amputation, with at least 1/5 having a history of peripheral neuropathy                                                                            
                                                                     (iii) Mean followup 16.2 months                                                                                                                                                                                                                                                                                                            
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

AFDA scoring system.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Two points each                                                                                        One point each
  ------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------
  \(i\) Peripheral neuropathy/loss of protective sensation \[[@B2], [@B23], [@B24], [@B28], [@B33]\]\    \(i\) Diabetic history of greater than 20 years \[[@B14], [@B23]\]\
  (ii) Presence of vasculopathy \[[@B2], [@B14], [@B28]\]\                                               (ii) Presence of nephropathy or retinopathy \[[@B6]\]\
  (iii) Insulin dependence with poor compliance \[[@B23]--[@B25], [@B30]\]\                              (iii) Obesity \[[@B14], [@B30]\]\
  (iv) Previous or coinciding history of Charcot\'s arthropathy in any joint \[[@B2], [@B14], [@B23]\]   (iv) Poor patient compliance

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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